Cell therapy, a new therapeutic approach that uses a patients own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment.NK cells are the bodys first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
Natural Killer Cells Therapeutics Market contains market size and forecasts of Natural Killer Cells Therapeutics in Global, including the following market information:
- Global Natural Killer Cells Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Natural Killer Cells Therapeutics market was valued at 1442.2 million in 2021 and is projected to reach US$ 2717.8 million by 2028, at a CAGR of 9.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
NK Cell Therapies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Natural Killer Cells Therapeutics include Affimed, Celgene, Fate Therapeutics, Fortress Biotech, Glycostem Therapeutics, Innate Pharma, Nantkwest, Nkarta Therapeutics and NKT Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Natural Killer Cells Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Natural Killer Cells Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Natural Killer Cells Therapeutics Market Segment Percentages, by Type, 2021 (%)
- NK Cell Therapies
- NK Cell Directed Antibodies
Global Natural Killer Cells Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Natural Killer Cells Therapeutics Market Segment Percentages, by Application, 2021 (%)
- Cancer
- Gastrointestinal Diseases
- Immunoproliferative Disorders
- Others
Global Natural Killer Cells Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Natural Killer Cells Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Natural Killer Cells Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Natural Killer Cells Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Affimed
- Celgene
- Fate Therapeutics
- Fortress Biotech
- Glycostem Therapeutics
- Innate Pharma
- Nantkwest
- Nkarta Therapeutics
- NKT Therapeutics
- Ziopharm Oncology
Industry Market Size
